US-based Glycoprox Biosciences to set up base at Technology Park Malaysia

KUALA LUMPUR: Glycoprox Biosciences Corporation (GPX) from San Francisco of the United States of America yesterday inked an agreement with TPM Biotech Sdn Bhd (TPMB) to set up its base in Malaysia at Technology Park Malaysia, Bukit Jalil, Kuala Lumpur.

GPX combines next generation glycomics, robust and reproducible instrumentation ( LC/ MS) and deep machine learning to augment cancer diagnosis, biomarker and target discovery for the development of more efficacious therapeutics.

The collaboration agreement was signed between GPX’s chief executive officer Aldo Carrascoso and president/ chief executive officer of Technology Park Malaysia Datuk Ir Mohd Azman Shahidin, witnessed by Datuk Seri Panglima Wilfred Madius Tangau, Minister of Science, Technology and Innovation, at the National Innovation and Creativity Economy 2017 (NICE 2017) exhibition.

Also present at the document exchange ceremony were Technology Park Malaysia Corporation Sdn Bhd ( TPM) chairman, Datuk Ahmad Fauzi Zahari and its TPM Biotech head Ema Ukhtiah Zakaria, as well as key officials from Malaysian Bioeconomy Corporation Sdn Bhd and captains of biotechnology industry.

Mohd Azman said the setting up of GPX’s base at TPMB’s molecular science laboratory is testimony of the former’s confidence in the state-of-the-art facilities and services available for the furtherance of their research and development programmes in Malaysia and South East Asia.

“We are indeed delighted to have a renowned company such as GPX to choose their operation base in Technology Park Malaysia and to collaborate with TPM Biotech, Azman added. — Bernama